Home
>
National Drug Code (NDC)
>
Acyclovir
Acyclovir - 55390-613-20 - (Acyclovir sodium)
Drug Information of Acyclovir
| Product NDC: | 55390-613 |
| Proprietary Name: | Acyclovir |
| Non Proprietary Name: | Acyclovir sodium |
| Active Ingredient(s): | 1000 mg/20mL & nbsp; Acyclovir sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Acyclovir
| Product NDC: | 55390-613 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074596 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970423 |
Package Information of Acyclovir
| Package NDC: | 55390-613-20 |
| Package Description: | 10 VIAL in 1 BOX (55390-613-20) > 20 mL in 1 VIAL |
NDC Information of Acyclovir
| NDC Code | 55390-613-20 |
| Proprietary Name | Acyclovir |
| Package Description | 10 VIAL in 1 BOX (55390-613-20) > 20 mL in 1 VIAL |
| Product NDC | 55390-613 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acyclovir sodium |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19970423 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | ACYCLOVIR SODIUM |
| Strength Number | 1000 |
| Strength Unit | mg/20mL |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
